logo

For the Inventor, By the Inventor

Stuttgart, Germany

Florian Von Der Mülbe

This inventor holds 20 USPTO granted patents and 17 published patent applications and 7 EPO patents. Top assignees: Curevac Ag, Curevac Real Estate Gmbh, Curevac Gmbh. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Florian Von Der Mülbe. Retrieved from https://idiyas.com/inventor/florian-von-der-mulbe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 60.0

 

Average Co-Inventor Count = 3.8

ph-index = 15

Forward Citations = 812(Granted Patents)


Location History:

  • Tubingen, DE (2012)
  • Tübingen, DE (2019)
  • Stuttgart, DE (2013 - 2023)

Company Filing History:

goldMedal10 out of 97 
 
Curevac Ag
 patents
silverMedal4 out of 9 
 
Curevac Real Estate Gmbh
 patents
bronzeMedal3 out of 5 
 
Curevac Gmbh
 patents
4. 3 out of 11 
 
Curevac Manufacturing Gmbh
 patents

Years Active: 2012-2025

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents
1. 12194148 - Lyophilization of RNA (2025-01-14),
2. 11661634 - Method for producing RNA (2023-05-30),
3. 11491112 - Lyophilization of RNA (2022-11-08),
4. 11446250 - Lyophilization of RNA (2022-09-20),
5. 11369691 - Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions (2022-06-28),
6. 11268157 - Method for producing RNA (2022-03-08),
7. 11135312 - Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions (2021-10-05),
8. 10780054 - Lyophilization of RNA (2020-09-22),
9. 10711315 - Method for producing RNA (2020-07-14),
10. 10568972 - Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions (2020-02-25),
11. 10188748 - Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions (2019-01-29),
12. 10017826 - Method for producing RNA (2018-07-10),
13. 9655955 - Application of mRNA for use as a therapeutic against tumour diseases (2017-05-23),
14. 9463228 - Application of mRNA for use as a therapeutic against tumour diseases (2016-10-11),
15. 9439956 - Application of mRNA for use as a therapeutic against tumour diseases (2016-09-13),

Title: Florian Von Der Mulbe: Innovator in mRNA Therapeutics

Introduction

Florian Von Der Mulbe is a prominent inventor based in Stuttgart, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of mRNA-based therapeutics. With a total of three patents to his name, his work is paving the way for innovative cancer treatments.

Latest Patents

One of his latest patents is focused on the application of mRNA for use as a therapeutic against tumor diseases. This invention relates to a pharmaceutical composition that includes at least one mRNA coding for an antigen from a tumor, combined with an aqueous solvent and preferably a cytokine, such as GM-CSF. This composition is particularly aimed at therapy and prophylaxis against cancer. Another notable patent is a method for purifying RNA on a preparative scale using HPLC. This method is distinguished by the use of a porous reversed phase as the stationary phase for RNA purification.

Career Highlights

Florian is currently associated with CureVac GmbH, a company known for its pioneering work in mRNA technology. His role at CureVac has allowed him to be at the forefront of research and development in this rapidly evolving field.

Collaborations

He has collaborated with notable colleagues such as Ingmar Hoerr and Steve Pascolo, who are also recognized for their contributions to mRNA research.

Conclusion

Florian Von Der Mulbe's innovative work in mRNA therapeutics is making a significant impact in the fight against cancer. His patents reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…